baber/WOPTO huggingface dataset:
Patent DE-69317343-D1 (DE)
Inventor: BERRY CHRISTOPHER
IPC: A61K38/55
Filed: 1993-09-02
Granted: 1998-04-16
Abstract: Use of a direct inhibitor of thrombin for the production of a drug (medicament) with thrombolytic activity.
Patent DE-69318803-D1 (DE)
Inventor: HOOTS JOHN E
IPC: G01M3/04
Filed: 1993-11-09
Granted: 1998-07-02
Abstract: Leakage is detected between a process fluid and a temperature-conditioning fluid, or from a process fluid to a temperature-conditioning fluid, in an industrial process. The industrial process includes an A and a B fluid, and one of the A and B fluids receives heat from or transfer heat to the other of the A and the B fluids by an indirect contact method, and one but not both of the A and the B fluids is an industrial process fluid. At least one specie of tracer chemical is maintained in the A fluid, and that specie of tracer chemical is not a normal component of the B fluid. At least one of the A and the B fluids is subjected to at least one analysis at least one site. Such analysis at least detects the presence of the specie of tracer chemical when the fluid subjected to the analysis is the B fluid, and such analysis at least detcrmines the concentration of the specie of tracer chemical when the fluid subjected to the analysis is the A fluid. <IMAGE>
Patent DE-69321823-D1 (DE)
Inventor: FUJITA TETSURO
IPC: A01N33/02
Filed: 1993-10-18
Granted: 1998-12-03
Abstract: A 2-amino-1,3-propanediol compound represented by general formula (I) or a pharmaceutically acceptable salt thereof, and an immunosuppressant containing the same as the active ingredient. In said formula R represents optionally substituted linear or branched carbon chain, optionally substituted aryl or optionally substituted cycloalkyl; and R<2>, R<3>, R<4> and R<5>, which may be the same or different from one another, represent each hydrogen, alkyl, aralkyl, acyl or alkoxycarbonyl. The compound is immunodepressant and useful as an inhibitor against rejection in organ or bone marrow transplantation, as a preventive or remedy for autoimmune diseases and so forth, or a reagent in the medical and pharmaceutical fields. <CHEM>
Patent DE-69331203-D1 (DE)
Inventor: SHERRY ALLAN DEAN
IPC: A61K49/06
Filed: 1993-06-28
Granted: 2002-01-03
Abstract: A nuclear magnetic resonance contrast composition which comprises a tetraazamacrocyclic compound - paramagnetic lanthanide complex having the formula: <CHEM>     where     x is 2, 3 or a combination of p 2(s) and   q 3(s) where p + q = 4;   R is (CH2)zP(=O)OR<1>OR<2>;   R<1> is H or CH3;   R<2> is CnH1+2n;   z is 1 to 3;   r is 2 or 3;   M is a paramagnetic lanthanide; and   n is 4 to 6.   The nuclear magnetic resonance contrast compositions are particularly suitable for liver imaging in a subject.
Patent DE-69401922-D1 (DE)
Inventor: FISHER MARK
IPC: B65D71/28
Filed: 1994-04-05
Granted: 1997-04-10
Abstract: There is provided a pack having a top wall (16) and side walls (18, 19) which retain and extend around the periphery of an arrangement of cans (11). Side wall (18) is formed from a multiple thickness of paperboard and has a handle aperture (26) formed in the multiple thickness. When lifted by the handle aperture (26) the grip of the side walls (18, 19) around the cans tends to tighten thereby increasing the rigidity of the pack.
Patent DE-69404917-D1 (DE)
Inventor: POWELL DENNIS
IPC: C07D217/20
Filed: 1994-06-29
Granted: 1997-09-18
Abstract: Compounds of the general formula: <CHEM> wherein R1, R2, R3, R4 and R5 are herein described, A is a straight or branched (C2-C12)alkyl or a phenyl moiety and B is a moiety of the formula: <CHEM> The compounds are effective in potentiating the activity of chemotherapeutic anti-cancer agents by increasing the sensitivity of multi-drug resistant cells to such chemotherapeutic agents.
Patent DE-69414148-D1 (DE)
Inventor: MARTIN THIERRY
IPC: E04F15/20
Filed: 1994-02-08
Granted: 1998-12-03
Abstract: The present invention relates principally to a method of producing a covering (1), particularly for floors, to a covering obtained by means of this method, as well as to a method of laying the said covering. According to the invention, grooves (2) are made, for example in sheets of wood, which are filled with flexible adhesive (3). After the adhesive has set, an ablation of the material between the grooves, advantageously over a depth less than the depth of the groove, uncovers the projecting contact strips.
Patent DE-69421717-D1 (DE)
Inventor: KIEMENEIJ FERDINAND DR
IPC: A61M25/16
Filed: 1994-12-15
Granted: 1999-12-23
Abstract: A preshaped tubular catheter for percutaneous transradial approach to catheterization, comprises a distal bridge shaped portion 1 having a distal arch defining a primary curve (3), a top defining a secondary curve (5), and a proximal arch defining a tertiary curve (7). The proximal arch is connected to a straight shaft (9). The shaft (9) is stiff and the bridge shaped portion has a flexibility extending at least up to and including the primary curve (3) and a stiffeness extending at least up to and including the tertiary curve (7). <IMAGE>
Patent DE-69426442-D1 (DE)
Inventor: FREEMAN CLARENCE S
IPC: H01B7/285
Filed: 1994-11-14
Granted: 2001-01-25
Abstract: A cable having a thixotropic filling compound therein, the filling compound being a gel composition including a water absorbent hydrocarbon polymer with pendent anionic groups. The composition eliminates shorts caused by moisture contact with such wires. The cable including the composition is stabilized against thermally induced capacitance changes and shows improved oxidation induction times. <IMAGE>
Patent DE-69428198-D1 (DE)
Inventor: KUNO ATSUSHI
IPC: C07D213/56
Filed: 1994-05-12
Granted: 2001-10-11
Abstract: PCT No. PCT/JP94/00786 Sec. 371 Date Nov. 9, 1995 Sec. 102(e) Date Nov. 9, 1995 PCT Filed May 12, 1994 PCT Pub. No. WO94/26709 PCT Pub. Date Nov. 24, 1994Guanidine derivatives of the formula:    <IMAGE>  (I)  wherein Y is C-R1 (in which R1 is hydrogen, lower alkyl, hydroxy, protected hydroxy, etc.,) R2 is pyrrolyl, tetrazolyl, pyrazolyl, etc., R3 is hydrogen, lower alkoxy, hydroxy, protected hydroxy, etc., Z is C-R4 (in which R4 is hydrogen, carboxy, protected carboxy, nitro, halogen, hydroxy(lower)alkyl, etc.,), and W is R12 (in which R12 is hydrogen, lower alkoxy, nitro, hydroxy or protected hydroxy) and pharmaceutically acceptable salts thereof which are useful as a medicament which are useful in inhibiting Na+/H+ exchange in cells and in the prevention of cardiovascular diseases, cerebrovascular diseases, renal diseases, arteriosclerosis and shock.
Patent DE-69435051-D1 (DE)
Inventor: OHNISHI TOSHIKAZU
IPC: H01J1/308
Filed: 1994-06-24
Granted: 2008-01-24
Abstract: An electron source comprising an electron-emitting device for emitting electrons according to input signals, characterized in that said electron-emitting device comprises a pair of oppositely disposed electrodes; and an electroconductive film arranged between the electrodes and including a high resistance region, wherein the high resistance region has a deposit containing carbon as a principal ingredient.
Patent DE-69506625-D1 (DE)
Inventor: RAVIER JEAN-MARIE
IPC: F16B5/06
Filed: 1995-06-15
Granted: 1999-01-28
Abstract: The fixing consists of a hollow stud (311) projecting from the sole plate (300) which is inserted through a hole (24) in the support bar (20). The stud wall is made from a compressible material, and has a blind inner channel (3100) connected to an aperture in the sole plate wall. Before the stud is inserted through the hole, a ball (4') of a solid material is pushed inside it. The stud containing the ball is made to pass through the hole by compressing the stud wall and applying pressure for it to pass through and be held in place. The stud is made from an elastomer material, and the ball of plastics or steel. <IMAGE>
Patent DE-69515547-D1 (DE)
Inventor: MILLER JAMES G
IPC: G01N33/48
Filed: 1995-04-28
Granted: 2000-04-20
Abstract: An incubator assembly (50) useful in a clinical analyzer having at least two incubators (52,54), each having a rotationally driven rotor assembly (60,80) having a plurality of slide element holding stations (68,88), which are stacked one above the other to define a substantially vertical arrangement. In a preferred embodiment, in which the incubators are of varying size, the smaller rotor assembly is horizontally offset so that the outside diameter of each rotor assembly is coincident in one location, preferably an input station, so that slide elements can be loaded into and removed more conveniently from either rotor assembly. <IMAGE>
Patent DE-69531687-D1 (DE)
Inventor: XIE XINGYUN
IPC: F16D55/02
Filed: 1995-06-30
Granted: 2003-10-09
Abstract: A brake, comprising a connecting mechanism enables the driving member to bring the driven member into their common movement, a fixed seat having friction surface and a braking part connected on the driven part; said connecting mechanism comprising an acting block and a driving block, the two can match together in relative movement and make relative movement when the driving member acquired active force or lost active force, enables the driven block making relative displacement on the direction of fitting or disengaging movement relative to the driven member, to realize braking or relieve braking for the driven member; said connecting mechanism also comprises a limiting mechanism, used for restricting the distance of relative movement of the acting block and driving block, and when braking or relieving braking has been accomplished, enables them to be in the state of common movement.
Patent DE-69533223-D1 (DE)
Inventor: RUBIN JEFFREY
IPC: A61K35/12
Filed: 1995-04-28
Granted: 2004-08-05
Abstract: A method of inducing the proliferation and/or differentiation of human fetal pancreatic cells entails contacting such cells in primary culture with Hepatocyte Growth Factor/Scatter Factor, thereby inducing a proliferation of  beta -epithelial cells, an increase in the number of  beta -epithelial cells which form islet-like cell clusters, and an increase in insulin production per cell. The method provides increased numbers of functional islet-like cell clusters for transplantation, for example, into Type 1 diabetic patients. The method can be scaled up so as to provide clinically useful numbers of cells for transplantation.
Patent DE-69618770-D1 (DE)
Inventor: BLOMFIELD THOMAS
IPC: B65D5/00
Filed: 1996-03-22
Granted: 2002-03-14
Abstract: PCT No. PCT/NZ96/00023 Sec. 371 Date Dec. 29, 1997 Sec. 102(e) Date Dec. 29, 1997 PCT Filed Mar. 22, 1996 PCT Pub. No. WO96/32329 PCT Pub. Date Oct. 17, 1996A container formed from a blank to define indexing longer walls having an inward incline but a double thickness provided by a foldline at the tops thereof so that the indexing projections are receivable within corresponding openings in the base of a corresponding container. Each part of the indexing walls has an extension such that at each end thereof one extension attaches to the outside of an end wall while the other attaches to the inside of an end wall with preferably that attaching to the inside of an end wall through a pair of parallel vertical folds providing a support at least in part for the weight of a stacked container.
Patent DE-69625363-D1 (DE)
Inventor: SUN LUYING
IPC: H01M10/0565
Filed: 1996-08-05
Granted: 2003-01-23
Abstract: This invention is directed to a novel solid polymer electrolyte more particularly thin film terpolymer networks are disclosed that are highly conductive at ambient temperatures. This solid polymer electrolyte can be produced as a thin film that results from the polymerization of three selected monomers together with a lithium salt and plasticizers. The resulting solid polymer electrolyte does have excellent mechanical properties and ionic conductivity at ambient temperatures and can be used in the fabrication of a solid state battery and other solid state electrochemical devices such as supercapacitors, fuel cells, sensors, electrochromic devices or the like.
Patent DE-69629826-D1 (DE)
Inventor: O'REILLY S
IPC: C12N5/06
Filed: 1996-10-23
Granted: 2003-10-09
Abstract: An inhibitor of endothelial cell proliferation, capable of inhibiting angiogenesis and causing tumor regression, that is approximately 20 kDa and corresponds to a C-terminal fragment of collagen type XVIII, and methods of treating angiogenesis-related disease.
Patent DE-69712439-D1 (DE)
Inventor: HATTON PHILIPPE
IPC: B65G17/00
Filed: 1997-10-24
Granted: 2002-06-13
Abstract: The support holding a ceramic product which is placed on a conveyor comprises a tray (12) with feet (3) whose upper and/or lower parts are shaped to have complementary male (7) and/or female (4) forms. These forms allow the support to be stacked, its precise positioning on a conveyor and its precise pick up by a transfer system.
Patent DE-69722023-D1 (DE)
Inventor: COOPER SIMON MURRAY
IPC: A61K31/56
Filed: 1997-10-23
Granted: 2003-06-18
Abstract: The invention relates to a new polymorphic crystalline form of S-fluoromethyl 6alpha,9alpha-difluoro-11beta-hydroxy-16alpha-methyl-3-oxo-17alpha-propionyloxyandrosta-1,4-diene-17beta-carbothiate (fluticasone propionate). The new polymorphic crystalline form is easily handled and easily fluidised and its particle size and shape can be controlled. The invention also relates to the use of this new material in therapy, particularly in the treatment of respiratory disorders, e.g. asthma.
Patent DE-69723779-D1 (DE)
Inventor: CASTANARES ETXEZARRETA AITOR
IPC: B60B17/00
Filed: 1997-06-09
Granted: 2003-09-04
Abstract: Noise damping system for railroad wheels, in which, on at least one of the side ends of the wheel hub a housing-mortise has been performed, the section of which has straight sides; housed in said mortise a ring (1) is provided which may be divided and which consists of torque means of the ring (1) in the mortise. For application in the railroad industry.
Patent DE-69736016-D1 (DE)
Inventor: RYAN ALLEN L
IPC: A63B24/00
Filed: 1997-06-17
Granted: 2006-07-06
Abstract: An exercise apparatus, comprises a frame (32) adapted for placement on the floor; a track (466) secured to said frame in a generally horizontal orientation; a pedal mechanism, including a pedal (56), slidably connected to said track (466); an ellipse generator (442,570) connected to said pedal mechanism so as to produce both a reciprocating motion of said pedal mechanism along said track (466) and a vertical motion of said pedal mechanism resulting in the movement of said pedal (56) in a generally elliptical path. <IMAGE>
Patent DE-69806956-D1 (DE)
Inventor: NGUYEN LY-LAN
IPC: A61K8/30
Filed: 1998-10-06
Granted: 2002-09-05
Abstract: The invention concerns a method for the permanent setting of keratin fibres and in particular hair, characterised in that it consists in: applying on the keratin fibres a composition reducing keratin, with adhesive capacity less than 15 g and a viscosity ranging between 0 and 2500 mpa's at a laminar flow rate of 100 s<SUP>-1 </SUP>and setting them; after sufficient setting time for reducing keratin, applying an oxidising composition, without intermediate rinsing of the fibres; rinsing after sufficient time for fixing the set fibres and reduced fibres in permanent setting; rinsing with water.
Patent DE-69816935-D1 (DE)
Inventor: VITEL JEAN-PIERRE
IPC: F16L21/06
Filed: 1998-10-22
Granted: 2003-09-11
Abstract: The sleeve (10) for assembling end to end of piping parts (2,4) comprises an elastomer tubular sealing cover (14). An external casing (12) comprises a longitudinally slit collar partially surrounding the cover is clamped (16) to the collar ends. The clamping comprises two flanges (18,20) each integral with one end of the collar and bolts (24) for pulling the two flanges together.
Patent DE-69821552-D1 (DE)
Inventor: HIRSBRUNNER PIERRE
IPC: C09K17/36
Filed: 1998-03-04
Granted: 2004-03-18
Abstract: The use of sodium or potassium methylsiliconate to render a substrate hydrophobic can be used to inhibit evaporation of water from a substrate or to reduce permeability to water.
Patent DE-69836228-D1 (DE)
Inventor: KUMAR SATYENDRA
IPC: G02F1/141
Filed: 1998-12-08
Granted: 2006-11-30
Abstract: A light modulating cell comprises a pair of substrates, alignment layers disposed on at least one of the substrates and a solution of polymerizable prepolymer and low molecular weight organic material disposed between the pair of substrates. The solution is phase separated and forms a layer of polymeric material and a layer of organic material between the two substrates. An external force may then be applied across the substrates to alter the optical appearance of the layer of organic material from one state to another. A photo-sensitive layer may also be provided in the cell.
Patent DE-69837094-D1 (DE)
Inventor: RAZ EYAL
IPC: A61P21/00
Filed: 1998-09-04
Granted: 2007-03-29
Abstract: The invention relates to methods for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation in tissue of an antigen-sensitized mammal host by delivering an immunostimulatory oligonucleotide to the host. In addition, methods for using the immunostimulatory oligonucleotides to boost a mammal host's immune responsiveness to a sensitizing antigen (without immunization of the host by the antigen) and shifting the host's immune responsiveness to a Th1 phenotype to achieve various therapeutic ends are provided. Kits for practicing the methods of the invention are also provided.
Patent DE-69908249-D1 (DE)
Inventor: GANDOLFI STEFANO
IPC: A47C27/06
Filed: 1999-07-02
Granted: 2003-07-03
Abstract: A mattress (10) with interactive elastic elements, comprising a number of hollow polyhedrons (11) with an octagonal base, made of an elastic and/or yielding material, arranged in longitudinal rows (12), interconnected and held in position within each row (12) by linings (18) made of a textile material enclosing the individual rows (12) of polyhedrons (11) or by guide bars (13) attaching to them by coupling devices (14) arranged on two lateral faces (15) opposing each other. Under the weight of an outstretched body (30) on the surface (21) of the mattress (10), each elastic polyhedron (11) compresses while bulging out transversally and exerting a pressure on the adjacent elastic elements (11), thus expanding them in length. <IMAGE>
Patent DE-69912633-D1 (DE)
Inventor: SELTZER RAYMOND
IPC: C09K15/20
Filed: 1999-10-11
Granted: 2003-12-11
Abstract: Pulps or papers, especially chemimechanical or thermomechanical pulps or papers, which still contain lignin, have enhanced resistance to yellowing when they contain an effective stabilizing amount of a N,N-dialkylhydroxylamine, an ester, amide or thio substituted N,N-dialkylhydroxylamine or N,N-dibenzylhydroxylamine or an ammonium salt thereof. This performance is often further enhanced by the presence of one or more coadditives selected from the group consisting of the UV absorbers, the polymeric inhibitors, the nitrones, the fluorescent whitening agents and metal chelating agents. Combinations of hydroxylamines or their salts, benzotriazole or benzophenone UV absorbers and a metal chelating agent are particularly effective. N,N-Diethylhydroxylamine and N,N-dibenzylhydroxylamine and their acid salts are surprisingly effective for this purpose.
Patent DE-69915059-D1 (DE)
Inventor: BURCHARDT REINHOLD
IPC: C07K14/78
Filed: 1999-05-17
Granted: 2004-04-01
Abstract: The present invention relates to monoclonal antibodies binding to the N-terminal procollagen (III) propeptide (PIIINP) molecule which is a proteolytic fragment emanating from the specific cleavage of procollagen (III) by N-proteinase after exocytosis and to an assay using these antibodies.
Patent DE-69922048-D1 (DE)
Inventor: WELTON JASON
IPC: C08L33/06
Filed: 1999-12-22
Granted: 2004-12-23
Abstract: The invention relates to a capstock polymer composition comprising a blend of a melt extrudable acrylic polymer component; from 10% to 50% by weight of a halogen donor component; a halogen volatilisation component; and a char-inducing component which induces formation of a char upon application of flame to the composition.
Patent DE-69922202-D1 (DE)
Inventor: KAJANDER E OLAVI
IPC: A01N63/04
Filed: 1999-07-01
Granted: 2004-12-30
Abstract: Nanobacteria contribute to pathological calcification in the human and animal body, including diseases such as kidney stones, salivary gland stones, dental pulp stones and atherosclerosis. The present invention provides methods for sterilizing articles contaminated with nanobacteria. The present invention also provides methods of treating patients infected with nanobacteria. In particular, the present invention provides a method for preventing the recurrence of kidney stones in a patient that has suffered from kidney stones, comprising administration of an antibiotic, a bisphosphonate, or a calcium chelator, either alone or in combination, in an amount effective to inhibit or prevent the growth and development of nanobacteria.
Patent DE-69923933-D1 (DE)
Inventor: TAROZZI FAUSTO
IPC: B65G49/08
Filed: 1999-12-14
Granted: 2005-04-07
Abstract: The kiln loading and unloading system, particularly for ceramic products, comprising a corresponding pair of horizontal conveyance platforms (3a, 3b) with motorized parallel and interposed rollers (4); each platform (3a, 3b) is aligned respectively between the inlet and the outlet of the kiln (2) and the transverse end portions of corresponding conveyance feed lines (5, 6) which merge in the platforms (3a, 3b); each platform (3a, 3b) is provided with a continuous co-planar extension (7) which is directed away from the kiln (2) and is divided into at least three consecutive sections (7a, 7b, 7c) which are individually motorized independently of each other; a first one (7a) of the sections, directed towards the kiln (2), and a second (7b) intermediate one of the sections are fixed in a co-planar arrangement, and at least one third end section (7c) is combined with lifting means (8) for raising it. <IMAGE>
Patent DE-69928312-D1 (DE)
Inventor: NEDEZ CHRISTOPHE
IPC: B01J23/72
Filed: 1999-03-23
Granted: 2005-12-22
Abstract: The elimination of halogenated compounds contained in a gas or a liquid is carried out by contacting the gas or the liquid in an alumina and/or hydrate alumina based composition and at least a compound A comprising at least of a metallic element chosen from group VII, IB and/or IIB of the periodic table. The metal's content is at most 45 wt.% wrt. the total weight of the composition. The composition is obtained as follows: (a) impregnation of one or several compounds (B) in alumina and/or hydrated alumina, followed by a thermal treatment at temperature greater or equal 100o C or between 200-1200o C or preferably 300-1000o C; (b) impregnation of one or several compounds (A) in alumina and/or hydrated alumina, followed by a thermal treatment at temperature greater or equal 100o C or between 150-600o C or preferably 200-550o C. It can also be obtained by starting with step (b) then step (a) or by introducing simultaneously A and B in alumina and/or hydrated alumina followed by the thermal treatment. In the latter case, the thermal treatment is carried out at 150-1200o C and/or preferably 200-1000o C.
Patent DE-69930919-D1 (DE)
Inventor: JOHNSON BRENT R
IPC: G06F11/273
Filed: 1999-11-16
Granted: 2006-05-24
Abstract: A system and method for transferring messages securely over a computer network which includes the steps of inputting the message to be transmitted at a first device and then encrypting the message at the first device. An address for a dynamically addressed server is obtained and the first device is connected to the dynamically addressed server. The encrypted message is transmitted from the first device to the server and the message is received at the dynamically addressed server. The message is transmit
Patent DE-69933763-D1 (DE)
Inventor: GOLDENBERG SEYMOUR
IPC: A61P3/10
Filed: 1999-05-14
Granted: 2006-12-07
Abstract: The present invention relates to sustained-release formulations using biodegradable alginate delayed gels or particles and methods thereof.